Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain
- PMID: 21507938
- PMCID: PMC3121356
- DOI: 10.1074/jbc.M111.236257
Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain
Abstract
Annular protofibrils (APFs) represent a new and distinct class of amyloid structures formed by disease-associated proteins. In vitro, these pore-like structures have been implicated in membrane permeabilization and ion homeostasis via pore formation. Still, evidence for their formation and relevance in vivo is lacking. Herein, we report that APFs are in a distinct pathway from fibril formation in vitro and in vivo. In human Alzheimer disease brain samples, amyloid-β APFs were associated with diffuse plaques, but not compact plaques; moreover, we show the formation of intracellular APFs. Our results together with previous studies suggest that the prevention of amyloid-β annular protofibril formation could be a relevant target for the prevention of amyloid-β toxicity in Alzheimer disease.
Figures





Similar articles
-
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains.FEBS Lett. 2011 Oct 3;585(19):3052-7. doi: 10.1016/j.febslet.2011.08.027. Epub 2011 Aug 24. FEBS Lett. 2011. PMID: 21872592
-
ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures.Amyloid. 2004 Mar;11(1):10-3. doi: 10.1080/13506120410001667872. Amyloid. 2004. PMID: 15185493
-
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.J Biol Chem. 2005 Feb 18;280(7):5892-901. doi: 10.1074/jbc.M404751200. Epub 2004 Dec 7. J Biol Chem. 2005. PMID: 15590663
-
Alzheimer's amyloid fibrils: structure and assembly.Biochim Biophys Acta. 2000 Jul 26;1502(1):16-30. doi: 10.1016/s0925-4439(00)00029-6. Biochim Biophys Acta. 2000. PMID: 10899428 Review.
-
In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.Subcell Biochem. 2012;65:53-74. doi: 10.1007/978-94-007-5416-4_3. Subcell Biochem. 2012. PMID: 23224999 Review.
Cited by
-
Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile.PLoS One. 2015 May 6;10(5):e0126317. doi: 10.1371/journal.pone.0126317. eCollection 2015. PLoS One. 2015. PMID: 25946042 Free PMC article.
-
Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration.Cell Rep. 2015 Jun 23;11(11):1760-71. doi: 10.1016/j.celrep.2015.05.021. Epub 2015 Jun 4. Cell Rep. 2015. PMID: 26051935 Free PMC article.
-
Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.Int J Mol Sci. 2018 May 31;19(6):1621. doi: 10.3390/ijms19061621. Int J Mol Sci. 2018. PMID: 29857474 Free PMC article. Review.
-
Rapid accumulation of endogenous tau oligomers in a rat model of traumatic brain injury: possible link between traumatic brain injury and sporadic tauopathies.J Biol Chem. 2013 Jun 7;288(23):17042-17050. doi: 10.1074/jbc.M113.472746. Epub 2013 Apr 30. J Biol Chem. 2013. PMID: 23632019 Free PMC article.
-
Potential mechanisms and implications for the formation of tau oligomeric strains.Crit Rev Biochem Mol Biol. 2016 Nov/Dec;51(6):482-496. doi: 10.1080/10409238.2016.1226251. Epub 2016 Sep 21. Crit Rev Biochem Mol Biol. 2016. PMID: 27650389 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical